- Lobbying
- Peter AND Duyshart
Lobbying Arrangements Results for 'Peter Duyshart'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to patient access. |
Pharmacosmos Therapeutics Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to domestic manufacturing of pharmaceuticals. |
Alvogen
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666). |
bluebird bio, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to health care accreditation, Medicare Advantage plans, including Medicare Advantage Special Needs Plans (SNP) reviews, telehealth, mental health parity, health equity, pharmacy bene... |
URAC, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to Medicare coverage and reimbursement of single-use endoscopy devices. |
EvoEndo, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to access to plasma-derived products and implementation of the Inflation Reduction Act (IRA, P. L. 117-169), including the Preserving Life-saving Access to Specialty Medicines in Ame... |
Grifols Shared Services North America, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to disease surveillance and pandemic preparedness, and the Pandemic All-Hazards Preparedness (PAHPA) reauthorization, including the Pandemic and All-Hazards Preparedness and Response... |
InductiveHealth Informatics
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to pharmacy benefit managers and the 340B Program. Issues related to pharmacy benefit managers and the 340B program. Issues related to the clinical and overall benefit of anti-obesit... |
Novo Nordisk, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Funding for research programs at the National Institute on Aging (NIA) and funding for geriatric workforce and academic career award programs at the Health Resources and Services Administration (HR... |
American Geriatrics Society
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369). |
Adaptive Biotechnologies
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to the manufacturing of infant formula and issues related to over-the-counter birth control. Issues related to the manufacturing of infant formula. |
Perrigo Company plc
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (Pub. L. No. 117-169), including implementation. Issues related to access, coverage, a... |
Exelixis, Inc.
Oncology-focused biotechnology company |
Arnold & Porter Kaye Scholer LLP | |||
Details Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 1199 ... |
Society of Nuclear Medicine and Molecular Imaging
|
Arnold & Porter Kaye Scholer LLP |